887 related articles for article (PubMed ID: 4248913)
1. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
2. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
[TBL] [Abstract][Full Text] [Related]
3. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
[TBL] [Abstract][Full Text] [Related]
4. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
6. Clot retraction facilitates clot lysis.
Carroll RC; Gerrard JM; Gilliam JM
Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
[TBL] [Abstract][Full Text] [Related]
7. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
8. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
[TBL] [Abstract][Full Text] [Related]
9. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
Lockhart MS; Comp PC; Taylor FB
J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
Torr-Brown SR; Sobel BE
Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
[TBL] [Abstract][Full Text] [Related]
11. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
Gilliam JM; Berkus V; Taylor FB
Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
[TBL] [Abstract][Full Text] [Related]
13. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
Haskel EJ; Eisenberg PR; Abendschein DR
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
[TBL] [Abstract][Full Text] [Related]
15. Factors responsible for ADP-induced release reaction of human platelets.
Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
[TBL] [Abstract][Full Text] [Related]
16. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
[No Abstract] [Full Text] [Related]
17. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
19. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
20. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]